Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of gauze packing, sponge-based, and hemostatic surgicel wound stasis dressings to treat hemorrhages from grade IV liver injuries: An experimental study.
Lashkarizadeh MM, Ghaedi A, Abolghasemi H, Rabiee M, Mehrabani D, Ahadian S, Bazrgar A, Moqbel Esfahani S, Paydar S. Lashkarizadeh MM, et al. Among authors: abolghasemi h. Heliyon. 2024 Oct 26;10(21):e39894. doi: 10.1016/j.heliyon.2024.e39894. eCollection 2024 Nov 15. Heliyon. 2024. PMID: 39539973 Free PMC article.
Revisiting double-negative T cells in autoimmune lymphoproliferative immunodeficiencies: a case series.
Jamee M, Sharafian S, Eslami N, Bayegi SN, Keramatipour M, Nabavi M, Shokri S, Shakiba M, Shamsian BS, Abolghasemi H, Vahidshahi K, Khanbabaee G, Armin S, Chavoshzadeh Z, Mesdaghi M. Jamee M, et al. Among authors: abolghasemi h. Allergol Immunopathol (Madr). 2024 Sep 1;52(5):6-14. doi: 10.15586/aei.v52i5.1115. eCollection 2024. Allergol Immunopathol (Madr). 2024. PMID: 39278845
Cytokine profile and antioxidants status in the moderate and severe COVID-19 patients: a trial of ozone therapy impact as a medicinal supplement.
Ghaleh HEG, Izadi M, Javanbakht M, Ghanei M, Einollahi B, Jafari NJ, Alishiri G, Aslani J, Abolghasemi H, Simonetti V, Khafaei M, Zhao S, Saadat SH, Ahmadi M, Parvin S, Vazifedoust S, Alvanagh AG. Ghaleh HEG, et al. Among authors: abolghasemi h. Inflammopharmacology. 2023 Dec;31(6):3029-3036. doi: 10.1007/s10787-023-01288-9. Epub 2023 Jul 12. Inflammopharmacology. 2023. PMID: 37436523
Patient and Physician Perspectives in the Management of Immune Thrombocytopenia in Iran: Responses from the ITP World Impact Survey (I-WISh).
Eshghi P, Abolghasemi H, Akhlaghi AA, Ashrafi F, Bordbar M, Hajifathali A, Hosseini H, Mirbehbahani N, Abedini A, Shahsavarani N, Faranoush M. Eshghi P, et al. Among authors: abolghasemi h. Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296221130335. doi: 10.1177/10760296221130335. Clin Appl Thromb Hemost. 2023. PMID: 36630731 Free PMC article.
Safety and immunogenicity of a recombinant receptor-binding domain-based protein subunit vaccine (Noora vaccine™) against COVID-19 in adults: A randomized, double-blind, placebo-controlled, Phase 1 trial.
Salimian J, Ahmadi A, Amani J, Olad G, Halabian R, Saffaei A, Arabfard M, Nasiri M, Nazarian S, Abolghasemi H, Alishiri G. Salimian J, et al. Among authors: abolghasemi h. J Med Virol. 2023 Feb;95(2):10.1002/jmv.28097. doi: 10.1002/jmv.28097. Epub 2022 Sep 13. J Med Virol. 2023. Retraction in: J Med Virol. 2024 Mar;96(3):e29509. doi: 10.1002/jmv.29509 PMID: 36029105 Free PMC article. Retracted. Clinical Trial.
98 results